Protocolised Management In Sepsis (ProMISe): a multicentre randomised controlled trial of the clinical effectiveness and cost-effectiveness of early, goal-directed, protocolised resuscitation for emerging septic shock
File(s)Protocolised Management In Sepsis (ProMISe).pdf (6.11 MB)
Published version
Author(s)
Type
Journal Article
Date Issued
2015-11-30
Date Acceptance
2015-07-31
Citation
Health Technology Assessment, 2015, 19 (97)
ISSN
1366-5278
Publisher
NIHR Health Technology Assessment Programme
Journal / Book Title
Health Technology Assessment
Volume
19
Issue
97
Copyright Statement
© Queen’s Printer and Controller of HMSO 2015. This work was produced by Mouncey et al. under the terms of a commissioning contract issued by the Secretary of State for Health. This issue may be freely reproduced for the purposes of private research and study and extracts (or indeed, the full report) may be included in professional journals provided that suitable acknowledgement is made and the reproduction is not associated with any form of advertising
Subjects
Science & Technology
Life Sciences & Biomedicine
Health Care Sciences & Services
QUALITY-OF-LIFE
ACTIVATED PROTEIN-C
SURVIVING SEPSIS
INTENSIVE-CARE
EMERGENCY-DEPARTMENT
INTERNATIONAL GUIDELINES
TRANSLATING RESEARCH
UNITED-STATES
ORGAN FAILURE
MORTALITY
Adult
Cost-Benefit Analysis
Disease Management
Emergency Service, Hospital
England
Guideline Adherence
Humans
Resuscitation
Shock, Septic
Technology Assessment, Biomedical
Treatment Outcome
Health Policy & Services
1117 Public Health And Health Services
0807 Library And Information Studies
0806 Information Systems
Publication Status
Published